Special Review and Analysis on 68 211 Prescriptions of Danhong Injection

ZHANG Tianjiao; LI Xue; CHEN Chao; DING Nan; LIU Yishu; ZHENG Peiyong; YANG Ming

doi:10.14009/j.issn.1672-2124.2023.01.023

您当前的位置：

首页 >

文章列表页 >

Special Review and Analysis on 68 211 Prescriptions of Danhong Injection

更新时间：2023-04-14

- Special Review and Analysis on 68 211 Prescriptions of Danhong Injection
- Issue 1, Pages: 112-115(2023)
- 作者机构：
  
  上海中医药大学附属龙华医院一期临床研究室
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2023.01.023
  CLC： R288
- Published：2023，
扫描看全文
ZHANG Tianjiao, LI Xue, CHEN Chao, et al. Special Review and Analysis on 68 211 Prescriptions of Danhong Injection. [J]. (1):112-115(2023)
DOI：

ZHANG Tianjiao, LI Xue, CHEN Chao, et al. Special Review and Analysis on 68 211 Prescriptions of Danhong Injection. [J]. (1):112-115(2023) DOI： 10.14009/j.issn.1672-2124.2023.01.023.

摘要

目的：了解该院住院处方中丹红注射液的使用情况，为临床用药提供参考，以提高处方质量以及用药的安全性、有效性。方法：从该院信息系统中抽取2018年1月至2022年2月使用丹红注射液的住院处方68 211张，使用该院自主研发的处方分析系统PA 2.1

对处方基本信息、临床诊断以及联合用药等进行专项点评。结果：68 211张住院丹红注射液处方中，不适宜处方共3 038张（占4.45%）

主要包括重复用药处方（3 018张，占4.42%）以及违反配伍禁忌处方（20张，占0.03%）;潜在风险处方共5 097张（占7.47%）

主要体现在潜在的药物相互作用。结论：该院丹红注射液的使用基本合理，但应防止处方中重复用药及配伍禁忌等问题，同时应注意其与高危药物联合应用时的药学监护工作，以促进合理用药。

Abstract

OBJECTIVE: To investigate the application of Danhong injection in inpatient prescriptions of the hospital

and to provide reference for clinical medication

so as to improve the quality of prescription and safety and effectiveness of medication. METHODS: From Jan. 2018 to Feb. 2022

68 211 inpatient prescriptions of Danhong injection were extracted from the information system of the hospital. The prescription analysis system PA 2.1 independently developed by the hospital was used to perform special review on basic prescription information

clinical diagnosis and drug combination. RESULTS: Of the 68 211 prescriptions of Danhong injection

there were 3 038 inappropriate prescriptions（4.45%）

mainly for repeated medication prescriptions（3 018 prescriptions

4.42%） and incompatible prescriptions（20 prescriptions

0.03%）. There were 5 097 potential risk prescriptions（7.47%）

mainly reflected in potential drug interactions. CONCLUSIONS: The application of Danhong injection in the hospital is basically reasonable

yet the problems such as repeated medication and incompatibility should be prevented. Meanwhile

attention should be paid to the pharmaceutical care when Danhong injection is used in combination with high-risk drugs to promote rational drug use.

关键词

丹红注射液处方专项点评联合用药药物相互作用

Keywords

Danhong injectionSpecial prescription reviewDrug combinationDrug interaction

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Post-Marketing Safety Monitoring and Re-Evaluation of Danhong Injection Based on Unbalanced Data Processing Method

Blood Concentration Monitoring of Digoxin in A Hospital and Its Influencing Factors

Medication Rationality in Fever Clinics in A Hospital from January 2019 to June 2022

Progress of Oxycodone Hydrochloride Combined with Other Drugs of Postoperative Patient-Controlled Analgesia

Related Author

TANG Jinfa

LI Weixia

CHEN Xiaofei

WANG Xiaoyan

ZHANG Hui

YANG Wei

WU Dongyuan

WU Yali

Related Institution

National Engineering Laboratory of Big Data Analysis and Application Technology, Institute of Basic Research in Clinical Medicine China Academy of Chinese Medical Sciences

Dept. of Biostatistics, University of Florida

Dept. of Pharmacy, the First Affiliated Hospital of Henan University of Chinese Medicine,Henan Province Engineering Research Center of Clinical Application, Evaluation And Transformation of Traditional Chinese Medicine, Henan Provincial Key Laboratory for Clinical Pharmacy of Traditional Chinese Medicine

Dept.of Pharmacy, Air Force General Hospital of PLA

Dept. of Pharmacy, China-Japan Friendship Hospital

⁰